Peninsula biotech’s drug for heavy menstrual bleeding approved by FDA, triggers $100M payment

The drug, in combination with a hormone and a contraceptive, will cost about $975 a month for women with heavy menstrual bleeding associated with uterine fibroids. It is the company's second FDA approval in six months, triggering a $100 million milestone payment from partner Pfizer Inc.